← back to search

Sean J. Barbour

Provincial Health Services Authority ·
🔎 Find collaborators in Nephrology · Pulmonary and Respiratory Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Nephrology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Renal Diseases and Glomerulopathies, Chronic Kidney Disease and Diabetes, Vasculitis and related conditions, and Renal Transplantation Outcomes and Treatments.
h-index
32
citations
4,277
works
86
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
New England Journal of Medicine 2025cited by 22position: middledoi
Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy
Journal of the American Society of Nephrology 2024cited by 48position: middledoi
Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis
Clinical Journal of the American Society of Nephrology 2024cited by 29position: firstdoi
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification
Kidney International 2023cited by 106position: middledoi
Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification
Mayo Clinic Proceedings 2023cited by 43position: middledoi
Immunoglobulin A nephropathy is characterized by anticommensal humoral immune responses
JCI Insight 2022cited by 48position: middledoi
Identifying Outcomes Important to Patients with Glomerular Disease and Their Caregivers
Clinical Journal of the American Society of Nephrology 2020cited by 97position: middledoi
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
New England Journal of Medicine 2019cited by 584position: middledoi
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy
JAMA Internal Medicine 2019cited by 466position: firstdoi
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International 2019cited by 185position: middledoi
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)
˜The œNephron journals/Nephron journals 2015cited by 68position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xuelian Wei · Verve Therapeutics (United States)2 papers (2024–2025)— · 2 papers (2024–2025)Robert Brenner · Indiana University School of Medicine2 papers (2024–2025)Vivekanand Jha · Rajamangala Institute of kidney disease2 papers (2024–2025)Jonathan Barratt · University of Leicester2 papers (2024–2025)Heather N. Reich · University Health Network2 papers (2019–2022)Richard Phoon · The University of Sydney2 papers (2024–2025)Richard Lafayette · Palo Alto University2 papers (2024–2025)Vladimı́r Tesař · University Hospital Cologne2 papers (2024–2025)Bart Maes · AZ Delta2 papers (2024–2025)Hong Zhang · King University2 papers (2019–2025)Daniel Cattran · University of Leicester2 papers (2019–2022)— · 1 papers (2019–2019)James An · Hospital for Sick Children1 papers (2022–2022)— · 1 papers (2025–2025)Harmeet Singh · University of Manitoba1 papers (2024–2024)Dana V. Rizk · University of Alabama at Birmingham1 papers (2025–2025)Jürgen Floege · University of Hong Kong1 papers (2024–2024)— · 1 papers (2019–2019)Michelle Hladunewich · Sunnybrook Health Science Centre1 papers (2022–2022)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Nephrology · Pulmonary and Respiratory Medicine →